Nurses and doctors at South Tees Hospitals NHS Foundation Trust have remarked on substantial time savings and safer ways of working, just hours after the go-live of a new digital noting solution.

The deployment of Miya Noting is an important part of the trust's electronic patient record programme, which is responding to urgent priorities faced by clinical teams through the Alcidion modular EPR, Miya Precision.

Clinisys announced that it has acquired Promium, a Bothell, Washington-based, leading provider of laboratory information management systems dedicated to supporting environmental, water, wastewater and other analytical testing laboratories that protect health and safety.

Digital health platform Luscii, market leader in the growing space of virtual hospital wards, has announced a new partnership with digital therapeutic EXI that will allow it to integrate physical activity into its care pathways for the first time.

With over 15 years' experience across 11 markets, and as a partner of NHS England, Luscii provides over 100 different care pathways.

Haut.AI, a SaaS company specializing in artificial intelligence for skin, hair, and wellness analytics, has just announced its new generative AI tech for modeling skin conditions - SkinGPT. This breakthrough in the beauty industry uses AI to create synthetic images and apply skin conditions to input image data. SkinGPT enables users to upload their photos and apply AI to simulate how their skin will change over time when using certain skincare products.

David Hancock, a long-standing expert on the health tech industry with a passion for interoperability, has become an associate of Highland Marketing.

In his new role, David will support clients of the specialist digital health agency that need advice on market entry or positioning, so they can communicate effectively with IT leaders at every level.

Insilico Medicine, a clinical-stage generative artificial intelligence (AI)-powered drug discovery company, has integrated advanced AI chat functionality based on recent advances in large language models into its PandaOmics platform. The new feature, "ChatPandaGPT," enables researchers to have natural language conversations with the platform and efficiently navigate and analyze large datasets, facilitating the discovery of potential therapeutic targets and biomarkers in a more efficient manner.

BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned, independently operated subsidiary of Bayer AG, announced a collaboration with Rune Labs and Emerald Innovations focused on using wearable and invisible contactless digital health technology to improve monitoring and data collection for Parkinson's disease clinical trials.